Pharma Deals Review, Vol 2009, No 8 (2009)

Font Size:  Small  Medium  Large

DxS and AstraZeneca Collaborate on Iressa® Diagnostic

Taskin Ahmed

Abstract


DxS, a personalised medicine company has inked an agreement with AstraZeneca to commercialise its TheraScreen EGFR29 as a companion diagnostic kit with AstraZeneca’s non-small cell lung cancer drug, Iressa® (gefitnib).



Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.